Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01868 | 34579068 | Nutrients | The Effect of Probiotics (MCP® BCMC® Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01877 | 34576091 | Int J Mol Sci | Establishment of an Adult Medaka Fatty Liver Model by Administration of a Gubra-Amylin-Nonalcoholic Steatohepatitis Diet Containing High Levels of Palmitic Acid and Fructose. | 2021 | Details |
| A01887 | 34572442 | Biomedicines | Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01902 | 34566663 | Front Pharmacol | Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies. | 2021 | Details |
| A01923 | 34560694 | Eur J Gastroenterol Hepatol | Healthcare practitioners' diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey. | 2022 | Details |
| A01931 | 34558856 | Hepatol Commun | Role of Cholesterol-Associated Steatohepatitis in the Development of NASH. | 2021 | Details |
| A01944 | 34557535 | Front Cardiovasc Med | Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment. | 2021 | Details |
| A01948 | 34557367 | Cureus | Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. | 2021 | Details |
| A01972 | 34547171 | Liver Int | The role of hepatic lipid composition in obesity-related metabolic disease. | 2021 | Details |
| A01985 | 34541964 | Expert Opin Pharmacother | Management of non-alcoholic fatty liver disease in patients with sarcopenia. | 2021 | Details |
| A01986 | 34540943 | Visc Med | Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD). | 2021 | Details |
| A01989 | 34537584 | Curr Opin Pharmacol | Genetic risk scores and personalization of care in fatty liver disease. | 2021 | Details |
| A02124 | 34497708 | Ther Adv Endocrinol Metab | Therapeutic approaches for non-alcoholic steatohepatitis. | 2021 | Details |
| A02137 | 34491886 | Gut Microbes | Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study. | 2022 | Details |
| A02146 | 34486981 | Endocr Connect | Nonalcoholic steatohepatitis: global impact and clinical consequences. | 2021 | Details |
| A02164 | 34478753 | Metabolism | Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk. | 2021 | Details |
| A02174 | 34474519 | Endocrinol Metab (Seoul) | Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability. | 2021 | Details |
| A02178 | 34473313 | Methods Mol Biol | Therapeutic Effects of Resveratrol on Nonalcoholic Fatty Liver Disease Through Inflammatory, Oxidative Stress, Metabolic, and Epigenetic Modifications. | 2022 | Details |
| A02191 | 34466334 | Cureus | Effective Treatment of Nonalcoholic Fatty Liver Disease Using a Community-Based Weight Management Program. | 2021 | Details |
| A02211 | 34459096 | Liver Int | Changing clinical management of NAFLD in Asia. | 2021 | Details |
| A02216 | 34456329 | Med Sci Monit | A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health. | 2021 | Details |
| A02228 | 34453359 | Hepatology | Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study. | 2021 | Details |
| A02233 | 34450307 | Pharmacol Res | Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis. | 2021 | Details |
| A02241 | 34449139 | Turk J Pediatr | The performance of shear wave elastography on evaluating liver changes in obese and overweight children. | 2021 | Details |
| A02250 | 34446275 | Maturitas | The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. | 2021 | Details |
| A02251 | 34446271 | Clin Ther | Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02262 | 34444750 | Nutrients | Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease. | 2021 | Details |
| A02268 | 34441028 | Medicina (Kaunas) | Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. | 2021 | Details |
| A02270 | 34440841 | Cells | Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02302 | 34430140 | Cureus | Rapid Onset of Weight Gain and Liver Dysfunction Successfully Treated With Nutrition and Exercise. | 2021 | Details |
| A02311 | 34423721 | Expert Rev Gastroenterol Hepatol | Metabolic disorders and the risk of cholangiocarcinoma. | 2021 | Details |
| A02316 | 34422077 | Evid Based Complement Alternat Med | The Efficacy of Rosa damascena on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial. | 2021 | Details |
| A02330 | 34416040 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations. | 2021 | Details |
| A02335 | 34414181 | Front Cell Dev Biol | Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders. | 2021 | Details |
| A02344 | 34410265 | J Pak Med Assoc | The frequency of non-alcoholic fatty liver disease in non-obese young medical professionals. | 2021 | Details |
| A02346 | 34408183 | Sci Rep | Key features of the environment promoting liver cancer in the absence of cirrhosis. | 2021 | Details |
| A02354 | 34405583 | Nurs Open | A qualitative study of self-management experiences in people with non-alcoholic fatty liver disease. | 2021 | Details |
| A02381 | 34396467 | Rev Endocr Metab Disord | Applications of artificial intelligence (AI) in researches on non-alcoholic fatty liver disease(NAFLD) : A systematic review. | 2021 | Details |
| A02389 | 34392687 | J Agric Food Chem | Understanding Choline Bioavailability and Utilization: First Step Toward Personalizing Choline Nutrition. | 2021 | Details |
| A02414 | 34382495 | Ann Med | Effects of PPM1K rs1440581 and rs7678928 on serum branched-chain amino acid levels and risk of cardiovascular disease. | 2021 | Details |
| A02435 | 34371968 | Nutrients | The Emerging Role of Sfrp5 and Wnt5a in the Pathogenesis of Obesity: Implications for a Healthy Diet and Lifestyle. | 2021 | Details |
| A02446 | 34368214 | Front Nutr | Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A02486 | 34357000 | Medicina (Kaunas) | Non-Alcoholic Fatty Liver Disease in Children. | 2021 | Details |
| A02499 | 34351306 | Horm Res Paediatr | Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps. | 2021 | Details |
| A02505 | 34348882 | Dig Liver Dis | Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease. | 2021 | Details |
| A02532 | 34339764 | J Hepatol | Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention. | 2021 | Details |
| A02552 | 34330514 | Clin Nutr ESPEN | Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms. | 2021 | Details |
| A02555 | 34330452 | Clin Nutr ESPEN | Polyphenols in the prevention and treatment of non-alcoholic fatty liver disease: An update of preclinical and clinical studies. | 2021 | Details |
| A02560 | 34328248 | Liver Int | Diet and exercise in NAFLD/NASH: Beyond the obvious. | 2021 | Details |
| A02569 | 34326816 | Front Endocrinol (Lausanne) | New Mammalian Glycerol-3-Phosphate Phosphatase: Role in β-Cell, Liver and Adipocyte Metabolism. | 2021 | Details |
| A02571 | 34326608 | World J Gastroenterol | Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion. | 2021 | Details |
| A02584 | 34322514 | Front Nutr | Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. | 2021 | Details |
| A02594 | 34321089 | Stem Cell Res Ther | Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells. | 2021 | Details |
| A02613 | 34309833 | Eur J Clin Invest | Is there an 'ideal' diet for patients with NAFLD? | 2021 | Details |
| A02620 | 34307250 | Front Pediatr | Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2021 | Details |
| A02637 | 34300021 | Int J Environ Res Public Health | The Impact of Nordic Walking on Bone Properties in Postmenopausal Women with Pre-Diabetes and Non-Alcohol Fatty Liver Disease. | 2021 | Details |
| A02654 | 34297346 | Curr Obes Rep | Endoscopic Procedures for Weight Loss. | 2021 | Details |
| A02661 | 34294580 | Dig Liver Dis | Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. | 2021 | Details |
| A02703 | 34277974 | Endocrinol Diabetes Metab | Impact of lifestyle Intervention on branched-chain amino acid catabolism and insulin sensitivity in adolescents with obesity. | 2021 | Details |
| A02708 | 34277236 | Cureus | The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2021 | Details |
| A02725 | 34272900 | Int J Eat Disord | Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A02781 | 34243193 | Semin Liver Dis | Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review. | 2021 | Details |
| A02832 | 34225483 | mBio | Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice. | 2021 | Details |
| A02855 | 34214678 | Clin Gastroenterol Hepatol | Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan. | 2021 | Details |
| A02858 | 34214382 | J Basic Clin Physiol Pharmacol | The effect of various high-fat diet on liver histology in the development of NAFLD models in mice. | 2021 | Details |
| A02859 | 34214346 | J Basic Clin Physiol Pharmacol | The effects of quercetin on the expression of SREBP-1c mRNA in high-fat diet-induced NAFLD in mice. | 2021 | Details |
| A02877 | 34208839 | J Pers Med | Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target. | 2021 | Details |
| A02906 | 34201382 | Nutrients | Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches. | 2021 | Details |
| A02914 | 34199535 | J Pers Med | Target Therapies for NASH/NAFLD: From the Molecular Aspect to the Pharmacological and Surgical Alternatives. | 2021 | Details |
| A02929 | 34193468 | BMJ Open Gastroenterol | Patient disease knowledge, attitudes and behaviours related to non-alcoholic fatty liver disease: a qualitative study. | 2021 | Details |
| A02938 | 34190778 | Arq Gastroenterol | EVALUATION OF REST ENERGY EXPENDITURE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A02942 | 34190160 | Medicine (Baltimore) | A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease. | 2021 | Details |
| A02952 | 34186359 | Diabetes Metab Syndr | Perceived barriers and facilitators for adherence to lifestyle prescription: Perspective of obese patients with non alcoholic fatty liver disease from north India. | 2021 | Details |
| A02976 | 34176536 | Nutr Res Rev | Carbohydrates deteriorate fatty liver by activating the inflammatory response. | 2021 | Details |
| A03001 | 34168615 | Front Endocrinol (Lausanne) | Unhealthy Lifestyle and Gut Dysbiosis: A Better Understanding of the Effects of Poor Diet and Nicotine on the Intestinal Microbiome. | 2021 | Details |
| A03005 | 34168043 | BMJ Open Gastroenterol | Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A03029 | 34159161 | Hepatobiliary Surg Nutr | Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactions. | 2021 | Details |
| A03035 | 34156017 | Wiad Lek | INFLUENCE OF COMPLEX TREATMENT ON BIOCHEMICAL BLOOD PARAMETERS OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND CONCOMITANT PRE-DIABETES. | 2021 | Details |
| A03038 | 34155801 | Liver Int | Management of NAFLD patients with advanced fibrosis. | 2021 | Details |
| A03039 | 34155799 | Liver Int | Current management of NAFLD/NASH. | 2021 | Details |
| A03040 | 34155798 | Liver Int | Non-alcoholic fatty liver disease in type 2 diabetes - A specific entity? | 2021 | Details |
| A03041 | 34155794 | Liver Int | New drugs for NASH. | 2021 | Details |
| A03077 | 34139786 | Semin Liver Dis | Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations. | 2021 | Details |
| A03093 | 34134495 | Cas Lek Cesk | Non-alcoholic fatty liver disease - how to effectively fight the nowadays most common liver disease? | 2021 | Details |
| A03101 | 34130852 | Semin Ultrasound CT MR | What's New in Hepatic Steatosis. | 2021 | Details |
| A03122 | 34120361 | Res Nurs Health | Development and initial validation of the nonalcoholic fatty liver disease self-management questionnaire. | 2021 | Details |
| A03124 | 34120338 | Eur J Clin Invest | Fit mothers for a healthy future: Breaking the intergenerational cycle of non-alcoholic fatty liver disease with maternal exercise. | 2021 | Details |
| A03142 | 34114650 | Cochrane Database Syst Rev | Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. | 2021 | Details |
| A03270 | 34065140 | Children (Basel) | Update on Metabolic Bariatric Surgery for Morbidly Obese Adolescents. | 2021 | Details |
| A03289 | 34059612 | Curr Opin Cardiol | Update on cardiovascular risk in nonalcoholic fatty liver disease. | 2021 | Details |
| A03298 | 34055494 | PeerJ | Liver proteome alterations in psychologically distressed rats and a nootropic drug. | 2021 | Details |
| A03299 | 34054728 | Front Endocrinol (Lausanne) | Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study. | 2021 | Details |
| A03312 | 34049388 | J Nutr | Consumption of Preserved Egg Is Associated with Modestly Increased Risk of Nonalcoholic Fatty Liver Disease in Chinese Adults. | 2021 | Details |
| A03321 | 34046015 | Front Endocrinol (Lausanne) | Epigenetics of Hepatic Insulin Resistance. | 2021 | Details |
| A03329 | 34043121 | Dig Dis Sci | Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention. | 2021 | Details |
| A03331 | 34041187 | J Family Med Prim Care | Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi. | 2021 | Details |
| A03339 | 34036255 | JHEP Rep | Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past. | 2021 | Details |
| A03349 | 34032283 | Eur J Clin Invest | Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver. | 2021 | Details |
| A03363 | 34027561 | Arch Toxicol | Infections at the nexus of metabolic-associated fatty liver disease. | 2021 | Details |
| A03366 | 34027276 | Hepatol Commun | The Patient's Perspective in Cirrhosis: Unmet Supportive Care Needs Differ by Disease Severity, Etiology, and Age. | 2021 | Details |